Association Among Metabolic Syndrome, Testosterone Level and Severity of Erectile Dysfunction
Article Outline
The purpose of this study was to determine the influence of metabolic syndrome (MS) and serum testosterone in patients with erectile dysfunction (ED) and their possible association. A total of 103 men with ED were enrolled. The International Index of Erectile Function (IIEF) questionnaire was used to assess erectile condition. MS was defined according to the criteria formulated by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the International Diabetes Federation (IDF). The mean age of the study population was 57.5 ± 10.7 years, with an average IIEF of 14.7 ± 6.7. The age and prevalence of MS using the NCEP ATP III criteria, but not the IDF criteria, were significantly different between mild and moderate/severe ED patients (p = 0.031 and 0.009, respectively). The percentage of hypertension (78.6% vs. 36.2%; p < 0.001) and raised fasting glucose levels (46.4% vs. 19.1%; p = 0.004) were significantly higher in the moderate/severe ED group, and both differences remained significant in multivariate analysis (p = 0.001 and 0.042, respectively). In addition, serum testosterone levels were significantly lower in ED patients with MS (p = 0.002). In summary, the presence of MS is associated with more severe ED. Among the components of MS, elevated blood pressure and fasting blood glucose were independent risk factors. NCEP ATP III criteria seem to correlate better with the degree of ED than the IDF definition. Our results also indicate that MS is associated with a lower testosterone level in patients with ED.
Key Words: erectile dysfunction , metabolic syndrome , testosterone
No full text is available. To read the body of this article, please view the PDF online.
References
- . Erectile dysfunction . N Engl J Med . 2000;342:1802–1813
- . Prevalence of erectile dysfunction: need for treatment? . Int J Impot Res . 2002;14:S22–S28
- The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study . Diabetes Care . 2003;26:3153–3159
- Clustering of metabolic factors and coronary heart disease . Arch Intern Med . 1999;159:1104–1109
- The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men . JAMA . 2002;288:2709–2716
- . Epidemiology of the metabolic syndrome, 2002 . Am J Manag Care . 2002;8:S283–S292
- High proportions of erectile dysfunction in men with the metabolic syndrome . Diabetes Care . 2005;28:1201–1203
- . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator . Heart . 2003;89:251–253
- Role of androgens in erectile function . J Urol . 2004;171:2358–2362
- Sex hormones, inflammation and the metabolic syndrome: a population-based study . Eur J Endocrinol . 2003;149:601–608
- Hypogonadism and metabolic syndrome: implications for testosterone therapy . J Urol . 2005;174:827–834
- The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction . Urology . 1997;49:822–830
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA . 2001;285:2486–2497
- The metabolic syndrome-a new worldwide definition . Lancet . 2005;366:1059–1062
- Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction . J Sex Med . 2005;2:96–103
- . The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction . J Urol . 2004;171:2341–2345
- Prevalence of erectile dysfunction in patients with metabolic syndrome . Int J Urol . 2006;13:385–388
- Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension . J Hypertens . 2005;23:233–246
- The patho-physiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function . Vasc Med . 2002;7:213–225
- . Obesity, the metabolic syndrome, and sexual dysfunction . Int J Impot Res . 2005;17:391–398
- Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial . JAMA . 2004;291:2978–2984
- Mediterranean diet improves erectile function in subjects with the metabolic syndrome . Int J Impot Res . 2006;18:405–410
- . Sexual dysfunction in hypertensive men. A critical review of the literature . Hypertension . 1988;12:1–10
- Hypertension is associated with severe erectile dysfunction . J Urol . 2000;164:1188–1191
- . Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort study . J Urol . 2005;174:244–248
- Association of type and duration of diabetes with erectile dysfunction in a large cohort of men . Diabetes Care . 2002;25:1458–1463
- Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus . Eur Urol . 2004;46:222–228
- Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both . Urology . 2004;64:1196–1201
- . Endothelial dysfunction in diabetic erectile dysfunction . Int J Impot Res . 2007;19:129–138
- . Erectile dysfunction and hypertension . Int J Impot Res . 2007;19:296–302
- Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging . J Clin Endocrinol Metab . 2001;86:724–731
- Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men . Int J Obes Relat Metab Disord . 2000;24:485–491
- . The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? . J Urol . 2006;176:1524–1527
- Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors . Endocrinology . 2006;147:141–154
- The effects of testosterone treatment on body composition and metabolism in middle-aged obese men . Int J Obes Relat Metab Disord . 1992;16:991–997
- Endogenous sex hormones and metabolic syndrome in aging men . J Clin Endocrinol Metab . 2005;90:2618–2623
- Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men . J Clin Endocrinol Metab . 2005;90:2636–2641
- . Body composition, metabolic syndrome and testosterone in ageing men . Int J Impot Res . 2007;19:448–457
PII: S1607-551X(08)70148-7
doi:10.1016/S1607-551X(08)70148-7
© 2008 Elsevier. Published by Elsevier Inc. All rights reserved.
